The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The incidence of inherited metabolic disorders in the West Midlands, UK
Open accessAbstract
BACKGROUND: Inherited metabolic disorders (IMDs) are a heterogeneous group of genetic conditions mostly occurring in childhood. They are individually rare but collectively numerous, causing substantial morbidity and mortality. AIMS: To obtain up-to-date estimates of the birth prevalence of IMDs in an ethnically diverse British population and to compare these estimates with those of other published population-based studies. METHODS: Retrospective data from the West Midlands Regional Diagnostic Laboratory for Inherited Metabolic Disorders (Birmingham, UK) for the 5 years (1999-2003) were examined. The West Midlands population of 5.2 million is approximately 10% of the UK population. Approximately 11% of the population of the region is from black and ethnic minority groups compared with approximately 8% for the the UK. RESULTS: The overall birth prevalence was 1 in 784 live births (95% confidence interval (CI) 619 to 970), based on a total of 396 new cases. The most frequent diagnoses were mitochondrial disorders (1 in 4929; 95% CI 2776 to 8953), lysosomal storage disorders (1 in 5175; 95% CI 2874 to 9551), amino acid disorders excluding phenylketonuria (1 in 5354; 95% CI 2943 to 9990) and organic acid disorders (1 in 7962; 95% CI 3837 to 17 301). Most of the diagnoses (72%) were made by the age of 15 years and one-third by the age of 1 year. CONCLUSIONS: These results are similar to those of the comparison studies, although the overall birth prevalence is higher in this study. This is probably due to the effects of ethnicity and consanguinity and increasing ascertainment. This study provides useful epidemiological information for those planning and providing services for patients with IMDs, including newborn screening, in the UK and similar populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
The frequency of lysosomal storage diseases in The Netherlands
Poorthuis, B. J. H. M., Wevers, R. A., Kleijer, W. J., Groener, J. E. M., de Jong, J. G. N., van Weely, S., Niezen-Koning, K. E., & van Diggelen, O. P. (1999) · Human Genetics · doi:10.1007/s004390051078 · Cited by 720
Screening Newborns for Inborn Errors of Metabolism by Tandem Mass Spectrometry
Wilcken, B., Wiley, V., Hammond, J., & Carpenter, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025225 · Cited by 677
Incidence of Inborn Errors of Metabolism in British Columbia, 1969–1996
Applegarth, D. A., Toone, J. R., & Lowry, R. A. R. B. (2000) · Pediatrics · doi:10.1542/peds.105.1.e10 · Cited by 407
Inborn errors of metabolism in the Italian pediatric population: A national retrospective survey
Dionisi-Vici, C., Rizzo, C., Burlina, A. B., Caruso, U., Sabetta, G., Uziel, G., & Abeni, D. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.122394 · Cited by 238
Newborn screening for inborn errors of metabolism: a systematic review.
Seymour, Thomason, Chalmers, Addison, Bain, Cockburn, Littlejohns, Lord, & Wilcox (1997) · Health Technology Assessment · doi:10.3310/hta1110 · Cited by 234
Pandor, A., Eastham, J., Beverley, C., Chilcott, J., & Paisley, S. (2004) · Health Technology Assessment · doi:10.3310/hta8120 · Cited by 201
Venditti, L. N., Venditti, C. P., Berry, G. T., Kaplan, P. B., Kaye, E. M., Glick, H. A., & Stanley, C. A. (2003) · PEDIATRICS · doi:10.1542/peds.112.5.1005 · Cited by 111
Cited by
Mitochondrial Disease: A Practical Approach for Primary Care Physicians
Haas, R. H., Parikh, S., Falk, M. J., Saneto, R. P., Wolf, N. I., Darin, N., & Cohen, B. H. (2007) · Pediatrics · doi:10.1542/peds.2007-0391 · Cited by 273
Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia
An, D., Schneller, J. L., Frassetto, A., Liang, S., Zhu, X., Park, J.-S., Theisen, M., Hong, S.-J., Zhou, J., Rajendran, R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.081 · Cited by 263
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease
Haas, R. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.008 · Cited by 92
Head, P. E., Myung, S., Chen, Y., Schneller, J. L., Wang, C., Duncan, N., Hoffman, P., Chang, D., Gebremariam, A., Gucek, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4772 · Cited by 52
Newborn screening for lysosomal storage disorders and other neuronopathic conditions
Matern, D., Oglesbee, D., & Tortorelli, S. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1117 · Cited by 41
Metadata
- Authors
- Sanderson, S., Green, A., Preece, M. A., & Burton, H.
- Venue
- Archives of Disease in Childhood
- Publisher
- BMJ
- Published
- 2006-11-01
- Volume
- 91
- Issue
- 11
- Pages
- 896-899
- ISSN
- 0003-9888 (ISSN-L)
- 1468-2044
- OpenAlex
- W2142626085
- Cited by
- 253
- References
- 20
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The incidence of inherited metabolic disorders in the West Midlands, UK. https://app.cochat.ai/papers/10.1136/adc.2005.091637
- The paper
- Sanderson, S., Green, A., Preece, M. A., & Burton, H. (2006). The incidence of inherited metabolic disorders in the West Midlands, UK. Archives of Disease in Childhood. https://doi.org/10.1136/adc.2005.091637
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.